Skip to content

Increasing Confidence in the Discovery of
Small Molecule Drugs

Improve your candidate's success by bringing human biology into early drug discovery
with the iPSC-based Ncardia platform

Contact us

Select the most promising drug candidate earlier with our robust and translational iPSC-platform

Navigating through target identification and validation, assay development, high-throughput screening, hit identification, and lead optimization to the selection of a preclinical candidate is not an ordinary process. It is associated with a high risk of failure and its subsequent economic and social losses.

Human induced pluripotent stem cell (iPSC) technology (handled by the right experts) is a powerful platform to introduce translational assays and instill greater confidence at every stage of drug discovery. It can be patient-specific, replicate key disease phenotypes, and provide robust results in the context of high-throughput screening.

Benefits of Ncardia Solutions

We facilitate your decision-making steps during the selection of drug candidates by integrating human models and clinically relevant readouts 

High reproducibility

Consistent results with our optimized assays

Predictive responses

Testing on relevant
human biology

Quick Turnaround

A team focused on timely delivery of reliable data

What we can do for you

We harness our expertise in iPSCs and multiple therapeutic areas to offer robust and predictive assays for: 

  • Target identification and validation
  • Hit identification
  • Hit-to-lead
  • Lead optimization

Whether you opt for our ready-to-use assays or require custom assay development, our expert team is ready to assist you. 

Services for Drug discovery with Small Molecules


Neuro ASOs

Download the poster to learn more about our iPSC platform

Your Trusted Partner to Maximize Long-term Success

Define your Needs

We sit together to understand your research goals and co-develop a plan

Plan the Process

We set a project plan with clear timelines and milestones

Execute and Report

Follow project progress with frequent and transparent communication

Plan for the Future

We explain the data and discuss how to support you in your next steps

 

Contact Us

If you're ready to explore how to accelerate your drug discovery pipeline with our leading iPSC-based platform, we'd welcome the opportunity to introduce you to Ncardia.

Chiara Formica, PhD Senior Scientist
Chiara 2